NASDAQ:MIRO

Miromatrix Medical (MIRO) Stock Forecast, Price & News

$1.00

+0.08 (+8.70%)

(As of 06/2/2023 ET)

Compare

Today's Range: $0.93
▼
$1.00
50-Day Range: $0.92
▼
$1.68
52-Week Range: $0.91
▼
$4.95

Volume: 13,595 shs
Average Volume: 43,301 shs
Market Capitalization: $27.24 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $3.00

Miromatrix Medical MarketRank™ Forecast

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 200.0% Upside
$3.00 Price Target
Short Interest: Healthy
2.15% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: 1.53
Based on 4 Articles This Week
Insider Trading: Acquiring Shares
$60,000 Bought Last Quarter
Proj. Earnings Growth: Growing
From ($1.05) to ($1.00) Per Share

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.30 out of 5 stars

Medical Sector

235th out of 983 stocks

Biological Products, Except Diagnostic Industry

30th out of 164 stocks

3.5

Analyst's Opinion

Consensus Rating
Miromatrix Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $3.00, Miromatrix Medical has a forecasted upside of 200.0% from its current price of $1.00.
Amount of Analyst Coverage
Miromatrix Medical has only been the subject of 1 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
2.15% of the float of Miromatrix Medical has been sold short.
Short Interest Ratio / Days to Cover
Miromatrix Medical has a short interest ratio ("days to cover") of 7.8.
Change versus previous month
Short interest in Miromatrix Medical has recently decreased by 1.69%, indicating that investor sentiment is improving.

0.0

Dividend Strength

Dividend Yield
Miromatrix Medical does not currently pay a dividend.
Dividend Growth
Miromatrix Medical does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for MIRO.

3.1

News and Social Media Coverage

News Sentiment
Miromatrix Medical has a news sentiment score of 1.53. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.56 average news sentiment score of Medical companies.
News Coverage This Week
MarketBeat has tracked 4 news articles for Miromatrix Medical this week, compared to 1 article on an average week.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Miromatrix Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $60,000.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
Only 5.20% of the stock of Miromatrix Medical is held by insiders.
Percentage Held by Institutions
Only 16.87% of the stock of Miromatrix Medical is held by institutions.

1.3

Earnings and Valuation

Earnings Growth
Earnings for Miromatrix Medical are expected to grow in the coming year, from ($1.05) to ($1.00) per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Miromatrix Medical is -0.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Miromatrix Medical is -0.70, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Miromatrix Medical has a P/B Ratio of 0.98. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

About Miromatrix Medical (NASDAQ:MIRO) Stock

Miromatrix Medical Inc., a life sciences company, develops a novel technology for bioengineering fully transplantable organs. Its proprietary technology is a platform that uses a two-step method of decellularization and recellularization designed to remove the porcine cells from the organs obtained from pigs and replace them with unmodified human cells. The company has collaborations with The Mayo Clinic, Mount Sinai Hospital, and The Texas Heart Institute. The company was formerly known as TayTech, Inc. Miromatrix Medical Inc. was incorporated in 2009 and is headquartered in Eden Prairie, Minnesota.

Receive MIRO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Miromatrix Medical and its competitors with MarketBeat's FREE daily newsletter.

MIRO Stock News Headlines

June 2, 2023 | finanznachrichten.de

Miromatrix Medical Inc.: Miromatrix Announces CEO Jeff Ross, Ph.D. will Expand His Role by Resuming Leadership of R&D

June 1, 2023 | finance.yahoo.com

Miromatrix Announces CEO Jeff Ross, Ph.D. will Expand His Role by Resuming Leadership of R&D

June 3, 2023 | Behind the Markets (Ad)

The single greatest medical breakthrough of all time?

We are on the cusp of a medical breakthrough. And soon, this single breakthrough could lead to the cure of over 6,000 genetic diseases, including Alzheimer's, heart disease, and even cancer! This reminds me of Amgen, where early investors made as much as 46,751% when they released their revolutionary drug to the market.

May 30, 2023 | finance.yahoo.com

Miromatrix Announces Participation in the 20th Annual Craig-Hallum Institutional Investor Conference

May 30, 2023 | finance.yahoo.com

Miromatrix Presenting at the 2023 American Transplant Congress

May 15, 2023 | americanbankingnews.com

Piper Sandler Cuts Miromatrix Medical (NASDAQ:MIRO) Price Target to $3.00

May 13, 2023 | msn.com

Piper Sandler Maintains Miromatrix Medical (MIRO) Overweight Recommendation

May 12, 2023 | markets.businessinsider.com

Piper Sandler Keeps Their Buy Rating on Miromatrix Medical (MIRO)

June 3, 2023 | Behind the Markets (Ad)

NOTICE: Your retirement is in immediate danger

Soon you may be forced to spend your afternoons packing grocery bags at Walmart instead of going to the park with your grandchildren. Why? Because not only could your money be worth even less than it already is now, but certain stocks and cryptocurrencies could drop by 80%. Even your social security check could be worth 21% less! Learn how to protect your retirement here >>>

May 12, 2023 | finanznachrichten.de

Miromatrix Medical Inc.: Miromatrix Reports First Quarter 2023 Results and Provides Corporate Update

May 11, 2023 | msn.com

Miromatrix Medical: Q1 Earnings Insights

May 11, 2023 | finance.yahoo.com

Miromatrix Medical Inc. (MIRO) Reports Q1 Loss, Misses Revenue Estimates

May 11, 2023 | finance.yahoo.com

Miromatrix Reports First Quarter 2023 Results and Provides Corporate Update

May 10, 2023 | markets.businessinsider.com

Miromatrix Medical is about to announce earnings — here's what Wall Street expects

May 10, 2023 | americanbankingnews.com

Miromatrix Medical (MIRO) Scheduled to Post Earnings on Thursday

April 27, 2023 | finance.yahoo.com

Miromatrix to Report First Quarter 2023 Financial Results

April 27, 2023 | americanbankingnews.com

Reviewing Caribou Biosciences (NASDAQ:CRBU) & Miromatrix Medical (NASDAQ:MIRO)

April 11, 2023 | americanbankingnews.com

Head-To-Head Comparison: Miromatrix Medical (NASDAQ:MIRO) versus BioCryst Pharmaceuticals (NASDAQ:BCRX)

April 10, 2023 | finance.yahoo.com

Miromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene Meeting on the Med

April 5, 2023 | americanbankingnews.com

Miromatrix Medical (NASDAQ:MIRO) PT Lowered to $6.00

April 3, 2023 | finance.yahoo.com

Multiple insiders bought Miromatrix Medical Inc. (NASDAQ:MIRO) stock earlier this year, a positive sign for shareholders

April 3, 2023 | americanbankingnews.com

Financial Analysis: Miromatrix Medical (NASDAQ:MIRO) and Omega Therapeutics (NASDAQ:OMGA)

April 2, 2023 | seekingalpha.com

Miromatrix Medical Inc. (MIRO) Q4 2022 Earnings Call Transcript

April 1, 2023 | americanbankingnews.com

Miromatrix Medical Inc. (NASDAQ:MIRO) CFO Buys $50,000.00 in Stock

March 31, 2023 | finance.yahoo.com

Miromatrix Medical Inc. (MIRO) Reports Q4 Loss, Tops Revenue Estimates

March 31, 2023 | markets.businessinsider.com

Craig-Hallum Reaffirms Their Buy Rating on CVRx (CVRX)

March 30, 2023 | msn.com

Earnings Preview For Miromatrix Medical

See More Headlines

MIRO Price History

30 days | 90 days | 365 days | Advanced Chart

MIRO Company Calendar

Last Earnings: 3/31/2023
Today: 6/03/2023
Next Earnings (Estimated): 8/21/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biological products, except diagnostic
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:MIRO
CUSIP: N/A
CIK: 1527096
Web: www.miromatrix.com
Phone: 952-942-6000
Fax: N/A
Employees: 36
Year Founded: N/A

Price Target and Rating

Average Stock Price Forecast: $3.00
High Stock Price Forecast: $3.00
Low Stock Price Forecast: $3.00
Forecasted Upside/Downside: +200.0%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.43)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-29,960,000.00
Net Margins: -3,169.39%
Pretax Margin: -3,169.39%
Return on Equity: -95.49%
Return on Assets: -76.90%

Debt

Debt-to-Equity Ratio: 0.01
Current Ratio: 8.23
Quick Ratio: 8.22

Sales & Book Value

Annual Sales: $950,000.00
Price / Sales: 28.67
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: $1.02 per share
Price / Book: 0.98

Miscellaneous

Outstanding Shares: 27,240,000
Free Float: 25,824,000
Market Cap: $27.24 million
Optionable: Not Optionable
Beta: -0.27

Key Executives

Dr. Jeffrey James Ross Ph.D. (Age 46)
CEO & Director
Comp: $566.75k

Mr. Brian D. Niebur CPA (Age 58)
CFO & VP of Fin.
Comp: $349.58k

Mr. James M. Douglas (Age 49)
CFO & Sec.

Mr. Tom Emig
VP of People & Culture

Dr. John Joseph Barry Ph.D.
VP of R&D

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

MIRO Stock - Frequently Asked Questions

Should I buy or sell Miromatrix Medical stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Miromatrix Medical in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" MIRO shares.
View MIRO analyst ratings or view top-rated stocks.
What is Miromatrix Medical's stock price forecast for 2023?: 1 Wall Street research analysts have issued 12 month price targets for Miromatrix Medical's shares. Their MIRO share price forecasts range from $3.00 to $3.00. On average, they anticipate the company's stock price to reach $3.00 in the next twelve months. This suggests a possible upside of 200.0% from the stock's current price.
View analysts price targets for MIRO or view top-rated stocks among Wall Street analysts.
How have MIRO shares performed in 2023?: Miromatrix Medical's stock was trading at $2.99 at the start of the year. Since then, MIRO shares have decreased by 66.6% and is now trading at $1.00.
View the best growth stocks for 2023 here.
When is Miromatrix Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Monday, August 21st 2023.
View our MIRO earnings forecast.
How were Miromatrix Medical's earnings last quarter?: Miromatrix Medical Inc. (NASDAQ:MIRO) posted its quarterly earnings results on Friday, March, 31st. The company reported ($0.33) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.37) by $0.04. The company had revenue of $0.93 million for the quarter, compared to the consensus estimate of $0.01 million. Miromatrix Medical had a negative trailing twelve-month return on equity of 95.49% and a negative net margin of 3,169.39%.
When did Miromatrix Medical IPO?: (MIRO) raised $32 million in an initial public offering (IPO) on Thursday, June 24th 2021. The company issued 4,000,000 shares at a price of $7.00-$9.00 per share. Craig-Hallum Capital Group acted as the underwriter for the IPO.

What is Miromatrix Medical's stock symbol?: Miromatrix Medical trades on the NASDAQ under the ticker symbol "MIRO."
Who are Miromatrix Medical's major shareholders?: Miromatrix Medical's stock is owned by a number of retail and institutional investors. Top institutional investors include First Light Asset Management LLC (8.21%), Gagnon Securities LLC (5.28%), Gagnon Advisors LLC (2.04%), RTW Investments LP (1.63%), G2 Investment Partners Management LLC (0.88%) and Perkins Capital Management Inc. (0.56%). Insiders that own company stock include James Michael Douglas and John Joseph Barry.
View institutional ownership trends.
How do I buy shares of Miromatrix Medical?: Shares of MIRO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.
What is Miromatrix Medical's stock price today?: One share of MIRO stock can currently be purchased for approximately $1.00.
How much money does Miromatrix Medical make?: Miromatrix Medical (NASDAQ:MIRO) has a market capitalization of $27.24 million and generates $950,000.00 in revenue each year. The company earns $-29,960,000.00 in net income (profit) each year or ($1.43) on an earnings per share basis.
How can I contact Miromatrix Medical?: The official website for the company is www.miromatrix.com. The company can be reached via phone at 952-942-6000 or via email at ir@miromatrix.com.

This page (NASDAQ:MIRO) was last updated on 6/3/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial